HormonaHormonaHormona
  • The Institute
  • Research
  • Teaching
  • NEWS
  • PUBLICATIONS
  • CONTACT
  • Português
  • Español
  • The Institute
  • Research
  • Teaching
  • NEWS
  • PUBLICATIONS
  • CONTACT
  • Português
  • Español

Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience.

Autores: Reddy J, Turan V, Bedoschi G, Moy F, Oktay K.
Publicado em: J Assist Reprod Genet. 2014 Jul;31(7):927-32.
Clique para leitura: https://www.ncbi.nlm.nih.gov/pubmed/?term=Triggering+final+oocyte+maturation+with+gonadotropin-releasing+hormone+agonist+(GnRHa)+versus+human+chorionic+gonadotropin+(hCG)+in+breast+cancer+patients+undergoing+fertility+preservation%3A+an+extended+++experience

Post navigation

← Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments. Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective? →
© INCT Hormona - Instituto Nacional de Ciência e Tecnologia em Hormônios e Saúde da Mulher

Desenvolvido por Estúdio BASS